Xiaobai Maimai Inc. operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, etc. It also offers consultancy and information technology support services; and trades in branded products, as well as promotes products. The company was formerly known as Hexindai Inc. and changed its name to Xiaobai Maimai Inc. in December 2020. Xiaobai Maimai Inc. was founded in 2014 and is headquartered in Beijing, China. As of July 13, 2021, Xiaobai Maimai Inc. operates as a subsidiary of Webao Limited.
IPO Year: 2017
Exchange: NASDAQ
Website: xiaobaimaimai.com
Fastest customizable press release news feed in the world
BEIJING, Dec. 16, 2021 /PRNewswire/ -- Akso Health Group ("Akso Health", the "Company" or "We") (NASDAQ:AHG), formerly known as Xiaobai Maimai Inc., today announced that the Company will update its name and ticker symbol on the Nasdaq Stock Market, effective at the start of trading on December 16, 2021 (the "Effective Date"). On the Effective Date, the Company's ADS and ordinary shares will be quoted under the new name "Akso Health Group" which was previously approved by the Company's shareholders (the "Name Change"), and the Company's ticker symbol will be updated to "AHG". Ms. Yilin Wang, Chairwoman and Chief Executive Officer of Akso Health, commented, "We are excited to align our Nasdaq
BEIJING, Dec. 15, 2021 /PRNewswire/ -- Akso Health Group (NASDAQ:AHG) ("Akso Health", the "Company" or "we"), formerly known as Xiaobai Maimai Inc., a social e-commerce platform in China, today announced its unaudited condensed consolidated financial results for the six months ended September 30, 2021. The Company amended the ratio of ADS and ordinary shares from one (1) ADS representing one (1) ordinary share to one (1) ADS representing three (3) ordinary shares, effective as of August 24, 2020. Fiscal year refers to the 12-month period ended March 31. First Half of Fiscal Year 2022 Highlights Number of Average Monthly Mobile Active Users[1] for the six months ended September 30, 2021 was 8
BEIJING, Dec. 3, 2021 /PRNewswire/ -- Xiaobai Maimai Inc. (NASDAQ:HX) ("Xiaobai Maimai" or the "Company"), today announced that it held the 2021 annual general meeting of shareholders (the "AGM") at the Meeting Room, Futian Shangri-La, 4088 Yi Tian Road, Futian District, Shenzhen 518408, People's Republic of China, at 10:00 a.m. (Beijing Time) on December 3, 2021. At the AGM, holders of 71,057,650 ordinary shares (including ordinary shares represented by the Company's American Depositary Shares), out of the 71,478,550 ordinary shares issued and outstanding, were present in person or by proxy, and therefore constituted a quorum of more than one-third of the ordinary shares outstanding and ent
BEIJING, Oct. 22, 2021 /PRNewswire/ -- Xiaobai Maimai Inc. (NASDAQ:HX) ("Xiaobai Maimai," the "Company," or "we"), today announced the appointment of Dr. Yingxian Liu as the medical consultant to the Company. Dr. Liu will work closely with management to develop the Company's cancer therapy and radiation oncology business by the Company's wholly-owned subsidiary, We Health Limited. Dr. Liu received his medical degree from Sun Yat-sen University of Medical Sciences in Guangzhou, China. He completed his pathology residency at North Shore University Hospital in Manhasset, New York. Dr. Liu completed his hematopathology fellowship at Albert Einstein College of Medicine at Montefiore Medical Cente
BEIJING, Sept. 28, 2021 /PRNewswire/ -- Xiaobai Maimai Inc. (NASDAQ:HX) ("Xiaobai Maimai", the "Company", or "we"), a social e-commerce platform in China, today announced that it plans to enter the radiation oncology services market in the U.S. The Company recently established We Health Limited, a subsidiary based in New York, to tap into the cancer therapy and radiation oncology business in the U.S. The Board of Directors (the "Board") has appointed Ms. Yilin (Linda) Wang to be Co-Chief Executive Officer. Ms. Wang has extensive experience in medical health, health management and medical technology related businesses. Cancer is a leading cause of death worldwide. According to the World Heal
BEIJING, July 28, 2021 /PRNewswire/ -- Xiaobai Maimai Inc. (NASDAQ:HX), formerly known as Hexindai Inc. ("Xiaobai Maimai", the "Company", or "we"), a social e-commerce platform in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended March 31, 2021 with the U.S. Securities and Exchange Commission ("SEC") on July 28, 2021. The annual report on Form 20-F, which contains its audited financial statements, can be accessed on the SEC's website at http://www.sec.gov as well as via the Company's investor relations website at http://ir.xiaobaimaimai.com. The Company will provide a hard copy of its annual report containing the audited consolidated financial stat
BEIJING, July 14, 2021 /PRNewswire/ -- Xiaobai Maimai Inc. (NASDAQ:HX), formerly known as Hexindai Inc. ("Xiaobai Maimai", the "Company", or "we"), a social e-commerce platform in China, today announced the appointment of Ms. Vivian Liu to its Board of Directors immediately, and that Ms. Luping Wei, Vice President of Operations and Director of the Company, has resigned for personal reasons effective July 14th, 2021. Ms. Wei's resignation did not result from any disagreement with the Company. Ms. Vivian Liu is currently the CEO of Hebei Chuangjie Technology Co., Ltd. and has extensive experience in financial investment, capital market operations and enterprise management. Prior to that, Ms.
BEIJING, March 11, 2021 /PRNewswire/ -- The "Social e-Commerce Enterprise Operational Service Standards" (the "Standards") was officially released by the Social e-Commerce Branch of China Association of Trade in Services (CATIS) in February 2021. Xiaobai Maimai Inc. (NASDAQ: HX), formerly known as Hexindai Inc. ("Xiaobai Maimai" or the "Company"), a social e-commerce platform in China, was one of the ten leading organizations that participated in the drafting of the Standards. The Standards defines the principle and business structure of social e-commerce services in China and outlines the fundamental requirements across the whole process of social e-commerce, from pre-transaction to after-s
BEIJING, Jan. 13, 2021 /PRNewswire/ -- Xiaobai Maimai Inc. (NASDAQ: HX), formerly known as Hexindai Inc. ("Xiaobai Maimai", the "Company", or "we"), a social e-commerce platform in China, today announced that it participated in the 2020 China Social e-Commerce Conference held in Beijing. Organized by the Social e-Commerce Branch of China Association of Trade in Services (CATIS), representatives from top social e-commerce platforms, live streaming e-commerce enterprises, suppliers, industry experts and government agencies attended the conference and discussed the value, compliance, best practice, and innovations of social e-commerce. During the conference, the draft version of "Social e-Co
BEIJING, Dec. 30, 2020 /PRNewswire/ -- Xiaobai Maimai Inc. (NASDAQ: HX), formerly known as Hexindai Inc. ("Xiaobai Maimai", the "Company", or "we"), a social e-commerce platform in China, today announced the closing of the assignment and assumption agreement dated December 16, 2020, by and among Beijing Hexin Yongheng Technology Development Co., Ltd. ("Hexin Yongheng"), a wholly-owned subsidiary of the Company, Kuaishangche Automobile Leasing Co., Ltd. ("Kuaishangche"), a company not directly associated with the Company but controlled by Mr. An, the CEO and Chairman of the board of directors of the Company, Hexin E-Commerce Company Limited ("Hexin E-Commerce"), and individual shareholders
424B3 - Xiaobai Maimai Inc. (0001702318) (Filer)
6-K - Xiaobai Maimai Inc. (0001702318) (Filer)
6-K - Xiaobai Maimai Inc. (0001702318) (Filer)
144 - Xiaobai Maimai Inc. (0001702318) (Subject)
6-K - Xiaobai Maimai Inc. (0001702318) (Filer)
6-K - Xiaobai Maimai Inc. (0001702318) (Filer)
6-K - Xiaobai Maimai Inc. (0001702318) (Filer)
6-K - Xiaobai Maimai Inc. (0001702318) (Filer)
6-K - Xiaobai Maimai Inc. (0001702318) (Filer)
6-K - Xiaobai Maimai Inc. (0001702318) (Filer)
Live Leadership Updates
BEIJING, Dec. 15, 2021 /PRNewswire/ -- Akso Health Group (NASDAQ:AHG) ("Akso Health", the "Company" or "we"), formerly known as Xiaobai Maimai Inc., a social e-commerce platform in China, today announced its unaudited condensed consolidated financial results for the six months ended September 30, 2021. The Company amended the ratio of ADS and ordinary shares from one (1) ADS representing one (1) ordinary share to one (1) ADS representing three (3) ordinary shares, effective as of August 24, 2020. Fiscal year refers to the 12-month period ended March 31. First Half of Fiscal Year 2022 Highlights Number of Average Monthly Mobile Active Users[1] for the six months ended September 30, 2021 was 8
BEIJING, Dec. 3, 2021 /PRNewswire/ -- Xiaobai Maimai Inc. (NASDAQ:HX) ("Xiaobai Maimai" or the "Company"), today announced that it held the 2021 annual general meeting of shareholders (the "AGM") at the Meeting Room, Futian Shangri-La, 4088 Yi Tian Road, Futian District, Shenzhen 518408, People's Republic of China, at 10:00 a.m. (Beijing Time) on December 3, 2021. At the AGM, holders of 71,057,650 ordinary shares (including ordinary shares represented by the Company's American Depositary Shares), out of the 71,478,550 ordinary shares issued and outstanding, were present in person or by proxy, and therefore constituted a quorum of more than one-third of the ordinary shares outstanding and ent
BEIJING, Oct. 22, 2021 /PRNewswire/ -- Xiaobai Maimai Inc. (NASDAQ:HX) ("Xiaobai Maimai," the "Company," or "we"), today announced the appointment of Dr. Yingxian Liu as the medical consultant to the Company. Dr. Liu will work closely with management to develop the Company's cancer therapy and radiation oncology business by the Company's wholly-owned subsidiary, We Health Limited. Dr. Liu received his medical degree from Sun Yat-sen University of Medical Sciences in Guangzhou, China. He completed his pathology residency at North Shore University Hospital in Manhasset, New York. Dr. Liu completed his hematopathology fellowship at Albert Einstein College of Medicine at Montefiore Medical Cente
BEIJING, July 14, 2021 /PRNewswire/ -- Xiaobai Maimai Inc. (NASDAQ:HX), formerly known as Hexindai Inc. ("Xiaobai Maimai", the "Company", or "we"), a social e-commerce platform in China, today announced the appointment of Ms. Vivian Liu to its Board of Directors immediately, and that Ms. Luping Wei, Vice President of Operations and Director of the Company, has resigned for personal reasons effective July 14th, 2021. Ms. Wei's resignation did not result from any disagreement with the Company. Ms. Vivian Liu is currently the CEO of Hebei Chuangjie Technology Co., Ltd. and has extensive experience in financial investment, capital market operations and enterprise management. Prior to that, Ms.
BEIJING, Dec. 30, 2020 /PRNewswire/ -- Xiaobai Maimai Inc. (NASDAQ: HX), formerly known as Hexindai Inc. ("Xiaobai Maimai", the "Company", or "we"), a social e-commerce platform in China, today announced the closing of the assignment and assumption agreement dated December 16, 2020, by and among Beijing Hexin Yongheng Technology Development Co., Ltd. ("Hexin Yongheng"), a wholly-owned subsidiary of the Company, Kuaishangche Automobile Leasing Co., Ltd. ("Kuaishangche"), a company not directly associated with the Company but controlled by Mr. An, the CEO and Chairman of the board of directors of the Company, Hexin E-Commerce Company Limited ("Hexin E-Commerce"), and individual shareholders
BEIJING, Dec. 16, 2020 /PRNewswire/ -- Hexindai Inc. (NASDAQ: HX) ("Hexindai" or the "Company"), a social e-commerce platform in China, today announced that it held the 2020 annual general meeting of shareholders (the "AGM") at the Conference Room, 5th Floor, Block C, Shimao Plaza, No. 92 Jianguo Road, Chaoyang District, Beijing 100020, People's Republic of China, at 10:00 a.m. (Beijing Time) on December 16, 2020. At the AGM, holders of 52,025,638 ordinary shares (including ordinary shares represented by the Company's American Depositary Shares), out of the 52,458,550 ordinary shares issued and outstanding, were present in person or by proxy, and therefore constituted a quorum of more tha
This live feed shows all institutional transactions in real time.
SC 13D - Xiaobai Maimai Inc. (0001702318) (Subject)
SC 13G/A - Xiaobai Maimai Inc. (0001702318) (Subject)
SC 13G/A - Xiaobai Maimai Inc. (0001702318) (Subject)